Pfizer says it will not have a coronavirus vaccine until late November, allaying fears of a rush for approval before Election Day

Pfizer chief executive Albert Bourla confirmed Friday the company will not file for regulatory authorization until the third week of November.

View original article
Contributor: Carolyn Y. Johnson